Compare GF & SMTI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | GF | SMTI |
|---|---|---|
| Founded | 1990 | 1982 |
| Country | Germany | United States |
| Employees | N/A | N/A |
| Industry | Investment Managers | Medical/Dental Instruments |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 184.9M | 182.6M |
| IPO Year | N/A | 2008 |
| Metric | GF | SMTI |
|---|---|---|
| Price | $11.24 | $18.78 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 2 |
| Target Price | N/A | ★ $41.00 |
| AVG Volume (30 Days) | 18.3K | ★ 51.7K |
| Earning Date | 01-01-0001 | 04-20-2026 |
| Dividend Yield | ★ 0.82% | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $15,586,976.00 |
| Revenue This Year | N/A | $20.66 |
| Revenue Next Year | N/A | $13.97 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ 32.47 |
| 52 Week Low | $8.80 | $18.29 |
| 52 Week High | $12.82 | $35.70 |
| Indicator | GF | SMTI |
|---|---|---|
| Relative Strength Index (RSI) | 24.91 | 37.65 |
| Support Level | $10.38 | $18.60 |
| Resistance Level | $11.62 | $21.18 |
| Average True Range (ATR) | 0.21 | 1.10 |
| MACD | -0.12 | 0.01 |
| Stochastic Oscillator | 0.00 | 19.38 |
NEW GERMANY FUND INC is a non-diversified, closed-end management investment company. As the investment objective, the fund seeks long-term capital appreciation through investment in middle-market German equities. The fund's portfolio of investment includes investments in different sectors such as the industrials, information technology, material, consumer discretionary, Communication Services, Financials, Consumer Staples, Real Estate, Utilities, Healthcare, Energy, and others. Its portfolio is geographically diversified across the Netherlands, Germany, and Luxembourg.
Sanara MedTech Inc is a medical technology company focused on developing and commercializing transformative technologies to improve clinical outcomes and reduce healthcare expenditures in the chronic and surgical wound and skincare markets. Its portfolio of products and services allows it to deliver comprehensive wound and skincare solutions for patients in all care settings, including acute and post-acute. Its surgical wound care products are CellerateRX Surgical Activated Collagen. Its chronic wound care products are BIAKOS Skin and Wound Cleanser, and BIAKOS Skin and Wound Gel.